Description
150 CASES OF CHROMAGER MRSA
Base award description: 144 CASES OF CHROMAGER MRSA
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-01+$8,702= $8,702
- Mod P000012014-09-09+$335= $9,036
- Mod P000022014-09-23+$56= $9,092
- Mod P000032014-10-22-$55= $9,037
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-01 | +$8,702 | $8,702 | 144 CASES OF CHROMAGER MRSA |
| Mod P00001· CHANGE ORDER | 2014-09-09 | +$335 | $9,036 | 150 CASES OF CHROMAGER MRSA |
| Mod P00002· CHANGE ORDER | 2014-09-23 | +$56 | $9,092 | 150 CASES OF CHROMAGER MRSA |
| Mod P00003· CLOSE OUT | 2014-10-22 | −$55 | $9,037 | 150 CASES OF CHROMAGER MRSA |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI DP4CNEMUF5F3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0457 | NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $147,256 | FY2026 |
| 36C25926N0454 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $114,883 | FY2026 |
| 36C25726N0477 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $337,374 | FY2026 |
| 36C25726D0094 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C24526P0552 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $98,508 | FY2026 |
| 36C24126N0587 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,457 | FY2026 |
Other recipients under 6640 from 540-CLARKSBURG (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24415F4637 | SEQIRUS USA INC | 540-CLARKSBURG | $10,000 | FY2015 |
| VA24414F1227 | FISHER SCIENTIFIC COMPANY L.L.C. | 540-CLARKSBURG | $14,567 | FY2014 |
| VA24414P1294 | PHARMALOGIC WV LTD | 540-CLARKSBURG | $3,680 | FY2014 |
| VA24414P0785 | BECKMAN COULTER, INC. | 540-CLARKSBURG | $62,095 | FY2014 |
| VA24414P0408 | CEPHEID | 540-CLARKSBURG | $19,818 | FY2014 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24414F4368_3600_V797P5109B_3600 · retrieved 2026-09-26.